Stay updated on Celecoxib Impact on SMN2 in SMA Clinical Trial
Sign up to get notified when there's something new on the Celecoxib Impact on SMN2 in SMA Clinical Trial page.

Latest updates to the Celecoxib Impact on SMN2 in SMA Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision tag changed from v3.2.0 to v3.3.2. This appears to be an internal version update and does not affect study information.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page no longer displays a general government funding and operating status banner. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedNo significant changes detected; only minor visual/layout tweaks with no impact on core content or function. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange Detected- Replaced the specific term 'Proximal spinal muscular atrophy' with the broader 'Spinal muscular atrophy' and incremented the revision version from v3.1.0 to v3.2.0. - Added a government-operations notice about funding, status, and references to cc.nih.gov and opm.gov. - The content now includes a general operating-status update rather than a prior more specific term.SummaryDifference4%

- Check70 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. Removed the 'Back to Top' link.SummaryDifference0.3%

Stay in the know with updates to Celecoxib Impact on SMN2 in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Celecoxib Impact on SMN2 in SMA Clinical Trial page.